Oral cavity and oropharyngeal squamous cell carcinoma—an update

AC Chi, TA Day, BW Neville - CA: a cancer journal for clinicians, 2015 - Wiley Online Library
Answer questions and earn CME/CNE Oral cavity squamous cell carcinoma (OC‐SCC) is
the most common malignancy of the head and neck (excluding nonmelanoma skin cancer) …

Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis

T Gupta, Z Master, S Kannan, JP Agarwal… - European journal of …, 2011 - Springer
Purpose Our objective was to conduct a systematic review and meta-analysis of studies
assessing the diagnostic performance of 18 F-fluorodeoxyglucose positron emission …

FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance

N Helsen, T Van den Wyngaert, L Carp… - European journal of …, 2018 - Springer
Purpose 18-fluorodeoxyglucose positron emission tomography combined with computed
tomography (FDG-PET/CT) is increasingly used to evaluate treatment response in head and …

Role of PET/CT in oropharyngeal cancers

EW Avery, K Joshi, S Mehra, A Mahajan - Cancers, 2023 - mdpi.com
Simple Summary This article reviews the role of positron emission tomography/computed
tomography (PET/CT) in the diagnosis and management of oropharyngeal cancers …

Temporal patterns of head and neck squamous cell carcinoma recurrence with positron‐emission tomography/computed tomography monitoring

DM Beswick, WE Gooding, JT Johnson… - The …, 2012 - Wiley Online Library
Abstract Objectives/Hypothesis: To estimate the distribution of head and neck squamous cell
carcinoma (HNSCC) recurrence after definitive chemoradiation therapy (CRT) among …

[HTML][HTML] 18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer

SA Kim, JL Roh, JS Kim, JH Lee, SH Lee… - European Journal of …, 2017 - Elsevier
Background Posttreatment detection of recurrence may lead to salvage treatment and
prognostic prediction in patients with head and neck squamous cell carcinoma (HNSCC) …

Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma

AS Leung, TJ Rath, MA Hughes, S Kim… - Head & …, 2016 - Wiley Online Library
Background The optimal timing for the initial posttreatment fluorodeoxyglucose (FDG)
positron emission tomography (PET)/CT scan after definitive treatment of head and neck …

18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy

N Helsen, D Roothans, B Van Den Heuvel… - PLoS …, 2017 - journals.plos.org
Objective The aim of this study is to evaluate the diagnostic performance of FDG-PET/CT for
the detection of residual disease after (chemo) radiotherapy in patients with head and neck …

Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614

WM Koch, JA Ridge, A Forastiere… - … of Otolaryngology–Head …, 2009 - jamanetwork.com
Objectives To compare the results of clinical and pathological staging for a large cohort of
patients with head and neck squamous cell carcinoma (HNSCC) and to examine patterns …

FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and …

Y Suenaga, K Kitajima, T Ishihara, R Sasaki… - European …, 2016 - Springer
Objective To evaluate the accuracy of PET/CT using 18 F-fluorodeoxyglucose (FDG) with IV
contrast for suspected recurrent head and neck squamous cell carcinoma (HNSCC) …